Burning Rock Biotech (BNR) Free Cash Flow (2019 - 2026)

Burning Rock Biotech (BNR) has reported Free Cash Flow for 8 consecutive years, with -$4.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Free Cash Flow fell 30.72% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at -$8.0 million (up 70.99% YoY), while the FY2025 annual figure was -$4.8 million, up 63.99% from the prior year.
• Free Cash Flow came in at -$4.2 million for Q1 2026 at Burning Rock Biotech, down from $3.3 million in the prior quarter.
• The five-year high for Free Cash Flow was $3.3 million in Q4 2025, with the low at -$22.7 million in Q1 2022.
• Average Free Cash Flow over 5 years is -$8.6 million, with a median of -$9.4 million recorded in 2025.
• The largest YoY upside for Free Cash Flow was 215.74% in 2024 against a maximum downside of 144.08% in 2024.
• Year by year, Free Cash Flow stood at -$9.5 million in 2022, then soared by 76.3% to -$2.3 million in 2023, then jumped by 215.74% to $2.6 million in 2024, then grew by 26.12% to $3.3 million in 2025, then slumped by 228.47% to -$4.2 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$4.2 million, $3.3 million, and $2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.